| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/07/2001 | CN1320425A Medicine for treating oral ulcer and its preparing process |
| 11/07/2001 | CN1320424A Application of sodium 3,4-dihydroxycinnamate in preparing antineoplastics |
| 11/07/2001 | CN1320423A Medicine composition and method for suppressing inter-racemization of L-amino acids |
| 11/07/2001 | CN1320422A Process for preparing Chinese-medicinal pills containing borneol |
| 11/07/2001 | CN1074414C indolylalkyl derivs. of benzodioxanmethylamine as 5-HT1A receptor ligands |
| 11/07/2001 | CN1074412C Novel 2,4-dioxopyrrolidine and 2,4-dioxotetrahydrofuran derivs. and medicines contg. same as active ingredient |
| 11/07/2001 | CN1074411C Method for preparing medicinal composition in noval physical form contg. heterocyclic amide deriv. |
| 11/07/2001 | CN1074279C Estradiol benzoate gel agent and its preparing method |
| 11/07/2001 | CN1074278C Process for producing sterile freeze-dried prostaglandin E1 powder injection |
| 11/06/2001 | USRE37438 Acetamidine derivatives and their use as inhibitors for the nitric oxide synthase |
| 11/06/2001 | US6313345 Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 11/06/2001 | US6313312 3-Azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 11/06/2001 | US6313311 Imidazole derivatives having affinity for alpha2 receptors |
| 11/06/2001 | US6313308 Methods for the preparation of biphenyl isoxazole sulfonamides |
| 11/06/2001 | US6313307 Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings |
| 11/06/2001 | US6313302 Opioid kappa receptor antagonists; side effect reduction; analgesics, antiinflammatory agents, anesthetics, and neuroprotectants |
| 11/06/2001 | US6313299 Antibacterial agents effective against methicillin resistant staphylococcus and streptococcus; 1,8-naphthrydine derivatives |
| 11/06/2001 | US6313298 Spiro-indolines as Y5 receptor antagonists |
| 11/06/2001 | US6313296 2-pyrrolidinone-1-acetic acid derivatives; viricides for human immunodeficiency virus (hiv); acquired immune deficiency syndrome (aids) treatment |
| 11/06/2001 | US6313290 Azolobenzazepine derivatives and compositions and method of use thereof |
| 11/06/2001 | US6313280 Suppresses brachyury-mediated transcription activation; hybrid screening assays; zinc finger domains; genetic engineering and expression |
| 11/06/2001 | US6313277 Breast cancer resistance protein (BCRP) and the DNA which encodes it |
| 11/06/2001 | US6313270 DbpB |
| 11/06/2001 | US6313264 Effector proteins of Rapamycin |
| 11/06/2001 | US6313247 Cinchonan based chiral selectors for separation of stereoisomers |
| 11/06/2001 | US6313214 Melanin inhibiting and cell growth activating compositions containing compounds having labdane structure |
| 11/06/2001 | US6313180 Steroid compounds having contraceptive and anti-osteoporosis activity |
| 11/06/2001 | US6313179 Treatment of hyperproliferative skin disorders with C18 to C20 aliphatic alcohols |
| 11/06/2001 | US6313178 For inhibit the growth of mycobacterium avium complex, in cancer therapy |
| 11/06/2001 | US6313176 Selecting an irreversible enzyme inhibitor as a medicament that is metabolized into an unwanted or adversive metabolite; placing irreversible enzyme inhibitor in a suitable formulation; administering formulation for therapy |
| 11/06/2001 | US6313175 For therapy of obesity; for quantitating the binding of serotonin or a serotonin ligand |
| 11/06/2001 | US6313174 Aminobenzophenones as inhibitors of interleukin and TNF |
| 11/06/2001 | US6313172 Administering hydroxyethylthiourea derivative for therapy of pain in mammal |
| 11/06/2001 | US6313171 Method for preventing or treating elevated blood lipid level-related diseases by administering cinnamic acid derivatives |
| 11/06/2001 | US6313170 For therapy of nutritional iron-deficiency anemia, blood loss anemia and hemolytic anemia in humans |
| 11/06/2001 | US6313169 Lutein esters having high bioavailability |
| 11/06/2001 | US6313168 Use of retinoid receptor antagonists in the treatment of cartilage and bone pathologies |
| 11/06/2001 | US6313165 Inhibition of cataracts and other disorders |
| 11/06/2001 | US6313164 Dithiolin derivatives, their preparation and their therapeutic effect |
| 11/06/2001 | US6313163 Administering 2,4-pentadienoic acid derivative for therapy of disease or condition responsive to therapy by retinoids |
| 11/06/2001 | US6313162 Propynyl or dienyl biaromatic compounds |
| 11/06/2001 | US6313160 Substituted heterocyclic compounds, method for preparing and compositions containing same |
| 11/06/2001 | US6313156 Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors |
| 11/06/2001 | US6313155 Composition and method for treating macular disorders |
| 11/06/2001 | US6313152 N(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| 11/06/2001 | US6313151 As inhibitors of factor xa and are used as anticoagulants in mammals |
| 11/06/2001 | US6313148 For therapy of pain pain associated with joint conditions such as rheumatoid arthritis and osteoarthritis, postoperative pain, post-partum pain, the pain associated with dental conditions such as dental caries and gingivitis |
| 11/06/2001 | US6313146 Calcium receptor-active molecules |
| 11/06/2001 | US6313145 Indoline derivatives useful as 5-HT-2C receptor antagonists |
| 11/06/2001 | US6313144 For therapy of gastro-esophageal reflux disease, emesis, dyspepsia |
| 11/06/2001 | US6313143 Substituted pyrroles |
| 11/06/2001 | US6313142 Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline |
| 11/06/2001 | US6313141 2-aminoalkylaminoquinolines as dopamine D4 ligands |
| 11/06/2001 | US6313140 Method of treatment using certain growth-hormone secret agogues |
| 11/06/2001 | US6313139 Administering benzylamine derivative for therapy of psychiatric disorder in mammals |
| 11/06/2001 | US6313137 Imidazo pyridine derivatives which inhibit gastric acid secretion |
| 11/06/2001 | US6313136 For therapy and prophylaxis of gastrointestinal inflammatory diseases |
| 11/06/2001 | US6313133 Orally administering an effective amount of a growth hormone secretagogue for enhancing quality of sleep in mammal |
| 11/06/2001 | US6313132 Therapeutically active diarylpropylamines; their pharmaceutically acceptable salts; a method for their preparation and method for their use |
| 11/06/2001 | US6313131 Therapy of renal colic by administering xanthine derivative in unit dosage form |
| 11/06/2001 | US6313130 JAK-3 inhibitors for treating allergic disorders |
| 11/06/2001 | US6313129 Therapeutic compounds |
| 11/06/2001 | US6313127 For therapy of hypercholesterolemia or atherosclerosis |
| 11/06/2001 | US6313125 Therapeutically active 1,2,4-triazolo[4.,3-B] pyridazine derivatives as ligands for GABA receptors |
| 11/06/2001 | US6313124 As corticotropin releasing factor (crf) antagonists used for therapy of anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases |
| 11/06/2001 | US6313123 Acetylenic sulfonamide thiol tace inhibitors |
| 11/06/2001 | US6313122 As inhibitors of factor xa and are used as anticoagulants in mammals |
| 11/06/2001 | US6313120 Treatment or prevention of diseases involving bradykinin receptors |
| 11/06/2001 | US6313118 Hydroxytryptamine receptor antagonists |
| 11/06/2001 | US6313117 Succinate derivative compounds useful as cysteine protease inhibitors |
| 11/06/2001 | US6313116 Phosphodiesterase inhibitors |
| 11/06/2001 | US6313115 Alleviate impairment of memory, or other cognitive functions caused by hypoglutamatergic condition or by deficiency in number or strength of excitatory synapses or in number of ampa receptors |
| 11/06/2001 | US6313112 Activating neuronal potassium adenosine triphosphate channels with diazoxide |
| 11/06/2001 | US6313111 Substituted 6H-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and pharmaceutical composition containing them |
| 11/06/2001 | US6313109 Prenyl transferase inhibitors |
| 11/06/2001 | US6313108 Treating androgen insufficiency |
| 11/06/2001 | US6313107 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 11/06/2001 | US6313106 Phospholipid derivatives of valproic acid and mixtures thereof |
| 11/06/2001 | US6313104 Organoprotective solutions |
| 11/06/2001 | US6313102 Stabilized dry composition comprising therapeutic agent susceptible to maillard reaction, further comprising reducing carbohydrate as stabilizer for therapeutic agent and inhibitor of maillard reaction |
| 11/06/2001 | US6313101 Antibiotics |
| 11/06/2001 | US6313100 Antibacterial, antiprotozoa agents |
| 11/06/2001 | US6312948 Retroviral vector for the transfer and expression of genes for therapeutic purposes in eukaryotic cells |
| 11/06/2001 | US6312907 An isolated nucleic acid encoding a gene for decorin binding protein from borrelia; diagnosis and therapy of lyme disease in humans and animals |
| 11/06/2001 | US6312898 Diagnosing and treating subjects having increased risk for the development of the disease using polymerase chain reaction and/or sequencing methods to determine amino acid polymorphism in the protein |
| 11/06/2001 | US6312753 Cocoa components, edible products having enriched polyphenol content, methods of making same and medical uses |
| 11/06/2001 | US6312737 The cancer cells can be leukemia cells and prostate cancer cells. |
| 11/06/2001 | US6312728 Drug delivery device with core, enteric polymer and coating |
| 11/06/2001 | US6312724 Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof |
| 11/06/2001 | US6312723 Compounds used in inhibiting gastric acid secretion 6-methoxy-2-(((4-methoxy-3, 5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1h-benzimidazole in tablet or capsule form with cyclodextrin |
| 11/06/2001 | US6312722 Pharmaceutical combined preparation, kit and method for hormonal contraception |
| 11/06/2001 | US6312718 Liposomal composition, b-cell malignancy antigen and lipids |
| 11/06/2001 | US6312717 Antidepressants or anti anxiety by administering azapirone and 5-ht1a autosomal receptor antagonist |
| 11/06/2001 | US6312716 Patch and method for transdermal delivery of bupropion base |
| 11/06/2001 | US6312712 Benzimidazole and cyclodextrin for gastric acid related diseases |
| 11/06/2001 | US6312708 Botulinum toxin implant |
| 11/06/2001 | US6312707 Treatment of sickle cell anemia crises with fructose-1,6-diphosphate as an analgesic drug |
| 11/06/2001 | US6312703 Drugs or cosmetics, liquid crystal solids and lecithin |
| 11/06/2001 | US6312692 Method of treating graft-versus-host disease with anti-GP39 antibodies and bone marrow cells |
| 11/06/2001 | US6312688 Tyrosine-phosphatase-related protein |